BW

AMPKγ1/2/3 (K78) polyclonal Antibody | BS2480

(No reviews yet) Write a Review
SKU:
BW-BS2480
Availability:
Usually ships in 5 working days
€1,098.00 - €1,647.00

Description

AMPKγ1/2/3 (K78) polyclonal Antibody | BS2480 | Gentaur UK, US & Europe Distribution

Host: Rabbit

Reactivity: Human,Mouse,Rat

Application: IHC IF

Application Range: IHC: 1:50~1:200 IF: 1:50~1:200

Background: The 5-AMP activated protein kinase (AMPK), a member of the SNF1 (sucrose non fermentor) kinase family, is a heterotrimeric protein comprise of alpha (63 kDa), beta (30 kDa) and gamma (38 kDa) subunits. The alpha subunit is the catalytic subunit, while beta and gamma are non catalytic subunits (although they have been found to interact with the active subunit in liver) . AMPK regulates fatty acid and sterol synthesis by phosphorylation of acetyl-CoA as well as cholesterol synthesis via phosphorylation and inactivation of hydroxymethylglutaryl-CoA reductase. AMPK is activated by AMP and can be also regulated by treatment with purified protein phosphatase in vitro.

Storage & Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Specificity: AMPKγ1/2/3 (K78) polyclonal Antibody detects endogenous levels of total AMPKγ protein.

Molecular Weight: ~ 38, 54, 63 kDa

Note: For research use only, not for use in diagnostic procedure.

Alternative Names: 5'-AMP-activated protein kinase subunit gamma-1; AMPK gamma1; AMPK subunit gamma-1; AMPKg; PRKAG1; AMPKγ1; AMPK-γ1; 5'-AMP-activated protein kinase subunit gamma-2; AMPK gamma2; AMPK subunit gamma-2; H91620p; PRKAG2; AMPKγ2; AMPK-γ2; 5'-AMP-activated protein kinase subunit gamma-3; AMPK gamma3; AMPK subunit gamma-3; PRKAG3; AMPKG3; AMPKγ3; AMPK-γ3;

Immunogen: Synthetic peptide, corresponding to amino acids 50-100 of Human AMPKγ1.

Conjugate: Unconjugated

Modification: Unmodification

Purification & Purity: The Antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE) .

Pathway:

View AllClose